Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America
Sonia Roman
Corresponding author
Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, and Health Sciences Center, University of Guadalajara, Mexico
Read
1218
Timeswas read the article
421
Total PDF
797
Total HTML
Share statistics
array:24 [ "pii" => "S1665268119304752" "issn" => "16652681" "doi" => "10.5604/01.3001.0012.0914" "estado" => "S300" "fechaPublicacion" => "2018-07-01" "aid" => "70296" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2018;17:541-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 104 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 47 "PDF" => 44 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119304764" "issn" => "16652681" "doi" => "10.5604/01.3001.0012.0915" "estado" => "S300" "fechaPublicacion" => "2018-07-01" "aid" => "70297" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2018;17:544-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 134 "formatos" => array:3 [ "EPUB" => 15 "HTML" => 63 "PDF" => 56 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Hepatitis E Virus: Still an Enigma in Mexico" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "544" "paginaFinal" => "546" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mauricio Realpe-Quintero, Oliver Viera-Segura, Nora A. Fierro" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Mauricio" "apellidos" => "Realpe-Quintero" ] 1 => array:2 [ "nombre" => "Oliver" "apellidos" => "Viera-Segura" ] 2 => array:2 [ "nombre" => "Nora A." "apellidos" => "Fierro" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119304764?idApp=UINPBA00004N" "url" => "/16652681/0000001700000004/v1_201906150923/S1665268119304764/v1_201906150923/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119304740" "issn" => "16652681" "doi" => "10.5604/01.3001.0012.0913" "estado" => "S300" "fechaPublicacion" => "2018-07-01" "aid" => "70295" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2018;17:539-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 123 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 62 "PDF" => 44 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Renovation of <span class="elsevierStyleItalic">Annals of Hepatology’s</span> Scientific Scope: Towards Preventing Rather Than Treating End-Stage Liver Disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "539" "paginaFinal" => "540" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Arturo Panduro, Claudio Tiribelli, Norberto C. Chávez-Tapia, Marco Arrese, Misael Uribe" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Arturo" "apellidos" => "Panduro" ] 1 => array:2 [ "nombre" => "Claudio" "apellidos" => "Tiribelli" ] 2 => array:2 [ "nombre" => "Norberto C." "apellidos" => "Chávez-Tapia" ] 3 => array:2 [ "nombre" => "Marco" "apellidos" => "Arrese" ] 4 => array:2 [ "nombre" => "Misael" "apellidos" => "Uribe" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119304740?idApp=UINPBA00004N" "url" => "/16652681/0000001700000004/v1_201906150923/S1665268119304740/v1_201906150923/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "titulo" => "Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "541" "paginaFinal" => "543" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Sonia Roman" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Sonia" "apellidos" => "Roman" "email" => array:1 [ 0 => "soniamariaroman@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, and Health Sciences Center, University of Guadalajara, Mexico" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondence and reprint request:" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall">Occult HBV infection (OBI) refers to the appearance of HBV DNA in the liver and/or serum (< 200 IU/mL) in HBsAg-negative patients with or without serologic markers of previous viral exposure.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> OBI constitutes a phase of chronic hepatitis B infection in which replication-competent viruses are actively suppressed by genetic, epigenetic and post-transcriptional mechanisms.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The clinical significance of OBI is of concern in risk patients coursing with post-transfusional hepatitis B infection, hepatitis B reactivation, chronic hepatitis, and hepatocellular carcinoma (HCC).<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="p0010" class="elsevierStylePara elsevierViewall">One of the main challenges for the management of OBI is the diagnosis. The detection of both HBsAg and HBV DNA is substantially reliant on the availability of highly sensitive and specific serological and molecular techniques, respectively. Worldwide, the performance of these diagnostic assays varies widely, thus, affecting the rate of prevalence of OBI among distinct risk groups.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Consequently, conventional criteria and standardized protocols for the detection of serum/liver HBV DNA were agreed (Taormina meeting, 2008).<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Thus, it was suggested that OBI positivity is confirmed by using nested polymerase chain reaction (PCR) primers annealing within at least two of the four open-reading frames of the HBV genome (S,C,P,X).</p><p id="p0015" class="elsevierStylePara elsevierViewall">In this issue of <span class="elsevierStyleItalic">Annals of Hematology</span>, Muto, <span class="elsevierStyleItalic">et al.</span> published the incidence and characteristics of OBI among 75 Japanese patients with HCC.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> In this study, OBI was detected in 38% of cryptogenic and 25.6% of hepatitis C patients with no other detectable risk factors (alcohol, steatosis), by using a highly sensitive, in-house PCR detection system for total HBV DNA and covalently-closed circular (ccc) DNA. Other HBV markers (HBsAg, anti-HBs, anti-HBc, Anti-HBe) were also measured. The authors concluded: “There was no correlation between OBI and anti-HBV antibodies, but fewer patients with OBI [compared to the non-OBI cases] had, high inflammatory activity, suggesting that factors other than inflammation may be involved in HCC carcinogenesis in patients with OBI.” This data suggests that the characteristics of OBI involved in HCC pathogenesis are variable; thus, creating the need of novel research and comparative analysis of the multiple risk factors interacting among different populations.</p><p id="p0020" class="elsevierStylePara elsevierViewall">One starting point of analysis is the global variances in the prevalence pattern of HCC. Estimates show that the age-adjusted incidence rate (AAIR) for HCC (all causes combined) is relatively low in the North and Latin America (LA) (1.5-3.0/100,000) compared to Eastern Asia (27.6 to 36.6/100,000).<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> One may ask what fraction of HCC is attributable to OBI. Another overlapping factor is the role of HBV genotype on the global epidemiology of OBI given their differential distribution among Asia, Europe and LA (B and C, A and D, F and H, respectively), as well as the degree of endemicity.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Further analysis would lead us to ask, how much data do we have on OBI from each of these regions. In agreement with the prevalence of HCC, statistics on OBI is more abundant in areas with higher overt hepatitis B infection rates and less in lower endemic localities.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> In contrast, in LA, a region with a diverse prevalence pattern of hepatitis B infection,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a>,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> there have been relatively few articles published in the last decade (2008–2018) related to OBI per country. OBI has been studied in native populations, blood donors, chronic hepatitis B and C patients, HIV patients, hemodialysis and pediatric patients.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Nonetheless, in regards to HCC and hepatitis B infection (overt or occult), this association is ultimately unexplored in LA, compared to Asia and Europe. This drawback may be due to limited in-depth research, lack of monitoring, the absence of high-sensitive detection assays, and unawareness among the medical community. Therefore, research aimed to diminish these limitations is warranted. In the case of Mexico, several studies have been performed to seek insight concerning the low incidence of HBV-related HCC. To date, it has been proposed that the endemic HBV genotype H may have imposed genetic adaptations on the host favoring a prompt suppression of HBV replication promoted by ethnic-related immune mechanisms.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a>,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Environmental factors could be the alkaline neutralization of potentially aflatoxin-contaminated maize-derived food products, reducing the risk of HCC regardless of the high prevalence of past infection (anti-HBc).<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Other reasons may be the premature death of patients with liver cirrhosis before the detection of HCC. Nonetheless, these explanations may not apply to all countries alike because each may have its own set of risk factors.</p><p id="p0025" class="elsevierStylePara elsevierViewall">Several reasons justify the need to study the risk factors involved in HCC in LA. One such evidence is the high OBI status among Mexican natives in high endemic regions (as in South America with HBV genotype F), blood donors, and patients with HIV or chronic liver disease.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a>,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> Additionally, the finding of genotype F (overt infection) in HCC cases in admixed populations of Argentina (or in others of Spain and Alaska) but not in South American natives reveals differential gene-environmental interactions.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> On the other hand, the influence of the non-endemic HBV genotypes A and D, (commonly found in European OBI cases) or of HBV genotypes B and C (related to the high rate of HCC in Asia) among the current population of LA requires further investigation. Other co-morbidities that override the presence of OBI are alcoholism, obesity, NASH and type 2 diabetes may impose further undetected liver damage.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Therefore, OBI diagnosis is essential. It is known that anti-HBc alone is a predictive signal of potential OBI and given the fluctuations of the HBV infection markers, testing for both HBsAg and anti-HBc at baseline and follow-up is recommended.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a>,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="p0030" class="elsevierStylePara elsevierViewall">In conclusion, the role of OBI and other causes involved in the epidemiology of HCC in LA are still unexplored risk factors. Genome-based research is required to decipher the role of genetics and interacting environmental risk factors in association with the natural history of HBV infection (including OBI) among the populations of LA, as well as the influence of other etiological agents that may cause chronic liver disease. Novel algorithms to detect OBI supported by basic/applied/clinical research are also necessary.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-05-07" "fechaAceptado" => "2018-05-07" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1124282" "palabras" => array:5 [ 0 => "Risk factor" 1 => "Epidemiology" 2 => "Hepatocellular carcinoma" 3 => "HBV genotypes" 4 => "Diagnostics" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abs0010" class="elsevierStyleSection elsevierViewall"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Occult hepatitis B infection (OBI) is the presence of hepatitis B virus (HBV) DNA in the liver and/or serum (< 200 IU/mL) in HBsAg-negative patients with or without serologic markers of previous viral exposure. The clinical significance of OBI is of concern in post-transfusional hepatitis B infection, hepatitis B reactivation, chronic liver disease and hepatocellular carcinoma (HCC). The diagnosis of OBI relays on the use of highly sensitive and specific laboratory techniques. Herein, comments derived from a study analyzing the frequency and characteristics of OBI in HCC Japanese patients are stated. While OBI and other causes of HCC have been highly studied in Asia and Europe, research in Latin America in these topics is limited. Several findings such as population risk groups with high prevalence of overt and OBI infection, HBV genotype F in Argentinean HCC patients, and the clinical impact of the foreign A-D genotypes suggest the need of further investigation. Additionally, alcoholism, obesity, NASH and type 2 diabetes may override the presence of OBI. Therefore, OBI diagnosis is essential. It is known that anti-HBc alone is a predictive signal of potential OBI and given the fluctuations of the HBV infection markers, testing for HBsAg and anti-HBc at baseline and follow-up is recommended. In conclusion, OBI and other causes involved in the epidemiology of HCC in Latin America are unexplored risk factors. Genome-based research is required to decipher the role of gene-environmental interactions associated with chronic liver disease. Novel algorithms to detect OBI supported by basic/applied/clinical research are also needed.</p></span>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0010" "bibliografiaReferencia" => array:11 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "What do we know about hepatitis B virus infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Saffioti F." 1 => "Raimondo G." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AMPM (Atti della Accademia Peloritana dei Pericolaanti-Classe di Scienze Medico-Biologiche)" "fecha" => "2017" "volumen" => "105" "numero" => "2" "paginaInicial" => "1" "paginaFinal" => "13" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Statements from the Taormina expert meeting on occult hepatitis B virus infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Raimondo G." 1 => "Allain J.P." 2 => "Brunetto M.R." 3 => "Buendia M.A." 4 => "Chen D.S." 5 => "Colombo M." 6 => "Craxi A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2008.07.014" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2008" "volumen" => "49" "paginaInicial" => "652" "paginaFinal" => "657" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18715666" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global epidemiology of occult HBV infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Allain J.P." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Ann Blood" "fecha" => "2017" "volumen" => "2" "paginaInicial" => "7" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency and characteristics of occult Hepatitis B infection among hepatocellular carcinoma patients in Japan" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Muto J." 1 => "Sugiyama M." 2 => "Shirabe K." 3 => "Mukaide M." 4 => "Kirikae-Muto I." 5 => "Ikegami T." 6 => "Yoshizumi T." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Annals Hepatol" "fecha" => "2018" "volumen" => "17" "paginaInicial" => "596" "paginaFinal" => "603" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatocellular Carcinoma in Latin America" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Pujol F.H." 1 => "Roman S." 2 => "Panduro A." 3 => "Navas M.C." 4 => "Lampe E." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "editores" => "CheminI." "titulo" => "Hepatocellular Carcinoma: A Global Challenge" "paginaInicial" => "55" "paginaFinal" => "68" "serieFecha" => "2012" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Occult HBV Infection: A faceless enemy in liver cancer development" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Morales-Romero J." 1 => "Vargas G." 2 => "García-Román R." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/v6041590" "Revista" => array:7 [ "tituloSerie" => "Viruses" "fecha" => "2014" "volumen" => "6" "paginaInicial" => "1590" "paginaFinal" => "1611" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24717680" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875018311859" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B virus infection in Latin America: A genomic medicine approach" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Roman S." 1 => "Jose-Abrego J." 2 => "Fierro N.A." 3 => "Escobedo-Melendez G." 4 => "Ojeda-Granados C." 5 => "Martinez-Lopez E." 6 => "Panduro A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v20.i23.7181" "Revista" => array:7 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2014" "volumen" => "20" "paginaInicial" => "7181" "paginaFinal" => "7196" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24966588" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1474442206704768" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distribution of HBV genotypes F and H in Mexico and Central America" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Panduro A." 1 => "Maldonado-Gonzalez M." 2 => "Fierro N.A." 3 => "Roman S." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3851/IMP2605" "Revista" => array:7 [ "tituloSerie" => "Antivir Ther" "fecha" => "2013" "volumen" => "18" "paginaInicial" => "475" "paginaFinal" => "484" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23792777" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875017318132" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B virus genotype H and environmental factors associated to the low prevalence of hepatocellular carcinoma in Mexico" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Roman S." 1 => "Fierro N.A." 2 => "Moreno-Luna L.E." 3 => "Panduro A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cancer Ther" "fecha" => "2013" "volumen" => "4" "paginaInicial" => "367" "paginaFinal" => "376" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B viruses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "de Gomes S.A." 1 => "Araujo N.A." 2 => "Flichman D." 3 => "Campos R." 4 => "Panduro A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "editores" => "LudertJ.E., PujolF.H., ArbizaJ." "titulo" => "Human Virology in Latin America. From Biology to Control" "paginaInicial" => "309" "paginaFinal" => "331" "serieFecha" => "2017" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Jose-Abrego A." 1 => "Panduro A." 2 => "Fierro N.A." 3 => "Roman S." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jmv.24913" "Revista" => array:7 [ "tituloSerie" => "J Med Virol" "fecha" => "2017" "volumen" => "89" "paginaInicial" => "2149" "paginaFinal" => "2157" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28792071" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875018311859" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001700000004/v1_201906150923/S1665268119304752/v1_201906150923/en/main.assets" "Apartado" => array:4 [ "identificador" => "77720" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001700000004/v1_201906150923/S1665268119304752/v1_201906150923/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119304752?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 0 | 1 | 1 |
| 2024 October | 17 | 4 | 21 |
| 2024 September | 15 | 10 | 25 |
| 2024 August | 8 | 3 | 11 |
| 2024 July | 19 | 6 | 25 |
| 2024 June | 7 | 7 | 14 |
| 2024 May | 19 | 5 | 24 |
| 2024 April | 37 | 6 | 43 |
| 2024 March | 12 | 6 | 18 |
| 2024 February | 20 | 4 | 24 |
| 2024 January | 24 | 4 | 28 |
| 2023 December | 15 | 6 | 21 |
| 2023 November | 10 | 4 | 14 |
| 2023 October | 13 | 4 | 17 |
| 2023 September | 13 | 2 | 15 |
| 2023 August | 15 | 6 | 21 |
| 2023 July | 16 | 5 | 21 |
| 2023 June | 33 | 4 | 37 |
| 2023 May | 66 | 4 | 70 |
| 2023 April | 46 | 2 | 48 |
| 2023 March | 24 | 4 | 28 |
| 2023 February | 20 | 4 | 24 |
| 2023 January | 6 | 3 | 9 |
| 2022 December | 7 | 7 | 14 |
| 2022 November | 10 | 11 | 21 |
| 2022 October | 11 | 7 | 18 |
| 2022 September | 6 | 6 | 12 |
| 2022 August | 12 | 9 | 21 |
| 2022 July | 12 | 7 | 19 |
| 2022 June | 11 | 9 | 20 |
| 2022 May | 8 | 11 | 19 |
| 2022 April | 11 | 16 | 27 |
| 2022 March | 11 | 8 | 19 |
| 2022 February | 7 | 5 | 12 |
| 2022 January | 14 | 7 | 21 |
| 2021 December | 10 | 7 | 17 |
| 2021 November | 5 | 8 | 13 |
| 2021 October | 11 | 9 | 20 |
| 2021 September | 4 | 10 | 14 |
| 2021 August | 8 | 11 | 19 |
| 2021 July | 9 | 6 | 15 |
| 2021 June | 8 | 12 | 20 |
| 2021 May | 12 | 6 | 18 |
| 2021 April | 24 | 23 | 47 |
| 2021 March | 6 | 4 | 10 |
| 2021 February | 7 | 6 | 13 |
| 2021 January | 6 | 8 | 14 |
| 2020 December | 4 | 7 | 11 |
| 2020 November | 5 | 5 | 10 |
| 2020 October | 4 | 6 | 10 |
| 2020 September | 15 | 9 | 24 |
| 2020 August | 9 | 9 | 18 |
| 2020 July | 7 | 8 | 15 |
| 2020 June | 3 | 2 | 5 |
| 2020 May | 8 | 7 | 15 |
| 2020 April | 4 | 2 | 6 |
| 2020 March | 3 | 4 | 7 |
| 2020 February | 7 | 2 | 9 |
| 2020 January | 4 | 5 | 9 |
| 2019 December | 10 | 8 | 18 |
| 2019 November | 8 | 2 | 10 |
| 2019 October | 9 | 4 | 13 |
| 2019 September | 5 | 4 | 9 |
| 2019 August | 0 | 2 | 2 |
| 2019 July | 5 | 10 | 15 |
| 2019 June | 2 | 8 | 10 |
Show all
